FK506 activates BMPR2, rescues endothelial dysfunction, and reverses pulmonary hypertension-Reference-Cited by-同舟云学术

FK506 activates BMPR2, rescues endothelial dysfunction, and reverses pulmonary hypertension

Published:2013-07-15 Issue:8 Volume:123 Page:3600-3613
ISSN:0021-9738
Container-title:Journal of Clinical Investigation
language:en
Short-container-title:J. Clin. Invest.

Author:

Spiekerkoetter Edda,Tian Xuefei,Cai Jie,Hopper Rachel K.,Sudheendra Deepti,Li Caiyun G.,El-Bizri Nesrine,Sawada Hirofumi,Haghighat Roxanna,Chan Roshelle,Haghighat Leila,de Jesus Perez Vinicio,Wang Lingli,Reddy Sushma,Zhao Mingming,Bernstein Daniel,Solow-Cordero David E.,Beachy Philip A.,Wandless Thomas J.,ten Dijke Peter,Rabinovitch Marlene

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Reference75 articles.

1. Cellular and molecular pathobiology of pulmonary arterial hypertension

2. The right ventricle in pulmonary hypertension

3. Modern Age Pathology of Pulmonary Arterial Hypertension

4. Familial Primary Pulmonary Hypertension (Gene PPH1) Is Caused by Mutations in the Bone Morphogenetic Protein Receptor–II Gene

5. Sporadic primary pulmonary hypertension is associated with germline mutations of the gene encoding BMPR-II, a receptor member of the TGF-beta family

Cited by 366 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hepatopulmonary Syndrome, Another Face of Dysregulated BMP9 Signaling;American Journal of Respiratory and Critical Care Medicine;2024-09-01

2. Disrupted BMP-9 Signaling Impairs Pulmonary Vascular Integrity in Hepatopulmonary Syndrome;American Journal of Respiratory and Critical Care Medicine;2024-09-01

3. How I treat bleeding in hereditary hemorrhagic telangiectasia;Blood;2024-08-29

4. New and Emerging Therapeutic Drugs for the Treatment of Pulmonary Arterial Hypertension: A Systematic Review;Cureus;2024-08-29

5. Research progress on the role of p53 in pulmonary arterial hypertension;Respiratory Investigation;2024-07